Eric A Adams In Med Pharmaceuticals Inc. (INM) insider trading activity

INM Quotes by TradingView

Eric A Adams is President & CEO of InMed Pharmaceuticals Inc.. Currently has a direct ownership of 43,959 shares of INM, which is worth approximately $11,429. The most recent transaction as insider was on Feb 20, 2024, when has been sold 41,600 shares (Common Stock) at a price of $0.36 per share, resulting in proceeds of $14,976. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K
0% 3M change
25.5% 12M change
Total Value Held $11,429

ERIC A ADAMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Open market or private purchase
$14,976 $0.36 p/Share
41,600 Added 48.62%
43,959 Common Stock
Apr 14 2022
BUY
Open market or private purchase
$12,602 $0.89 p/Share
14,160 Added 19.35%
59,003 Common Stock
Apr 13 2022
BUY
Open market or private purchase
$7,276 $0.85 p/Share
8,560 Added 16.03%
44,843 Common Stock
Sep 29 2021
BUY
Open market or private purchase
$15,224 $1.73 p/Share
8,800 Added 19.52%
36,283 Common Stock
Sep 28 2021
BUY
Open market or private purchase
$19,950 $1.75 p/Share
11,400 Added 29.32%
27,483 Common Stock
EAA

Eric A Adams

President & CEO
Vancouver, A1

Track Institutional and Insider Activities on INM

Follow InMed Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INM shares.

Notify only if

Insider Trading

Get notified when an In Med Pharmaceuticals Inc. insider buys or sells INM shares.

Notify only if

News

Receive news related to InMed Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INM